OptiBiotix Health PLC (LON:OPTI)‘s stock had its “corporate” rating restated by equities researchers at FinnCap in a research note issued to investors on Wednesday.

Shares of OptiBiotix Health PLC (LON OPTI) opened at 70.00 on Wednesday. The firm has a 50-day moving average of GBX 64.50 and a 200 day moving average of GBX 70.78. OptiBiotix Health PLC has a 52 week low of GBX 59.00 and a 52 week high of GBX 90.00. The company’s market cap is GBX 54.71 million.

TRADEMARK VIOLATION NOTICE: “OptiBiotix Health PLC (OPTI) Stock Rating Reaffirmed by FinnCap” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this article on another publication, it was illegally stolen and republished in violation of United States and international copyright and trademark legislation. The correct version of this article can be read at https://www.thecerbatgem.com/2017/09/01/optibiotix-health-plc-opti-stock-rating-reaffirmed-by-finncap.html.

About OptiBiotix Health PLC

Optibiotix Health Plc is a life sciences company developing a range of products to modify the human microbiome. The Company’s principal activity is research and development into microbiome modulators. It operates in UK segment. The Company has a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression.

Receive News & Stock Ratings for OptiBiotix Health PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiBiotix Health PLC and related stocks with our FREE daily email newsletter.